IRCT20221121056563N1
Comparision of the effect of vitamin D3 and probiotic containing lactic acid bacteria co-supplementation with vitamin D3 on serum 25(OH)D levels in patients with polycystic ovary syndrome.
Oroumia University of Medical Sciences·Phase 3·Iranian Registry Of Clinical Trial·otherRecruiting
Study focus
- Disease/Condition
- Polycystic ovarian syndrome
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Oroumia University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Dec 02, 2022
- End date
- N/A
ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionOther and unspecified ovarian cysts
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20221121056563N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20221121056563N1 through Pure Global AI's free database. This Phase 3 trial is sponsored by Oroumia University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.